Yisheng receives approval for rabies vaccine clinical study

Oct 18, 2018

The PIKA rabies vaccine has completed Phase I and Phase II clinical studies in Singapore.   Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immune modulator biotherapeutics and vaccines, has announced that ...

Read More

Blockchain to Combat Type 2 Diabetes Epidemic in India

Oct 3, 2018

Genomics pioneer Shivom hopes to transform diagnosis and treatment of a disease that’s pervasive in the country. London, UK – 25 September 2018: A pioneering diabetes pilot to collect, sequence and analyze DNA in India, with the aim of using ...

Read More